Recruiting NA Sedative During Endoscopy

New treatment option for Sedative During Endoscopy

Official title Implementing Virtual Reality (VR) to Reduce Sedation

ClinicalTrials.gov ID: NCT06349564

What this study is testing

What it's testing
The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 65. Healthy volunteers may be eligible.

You may be able to join if

  • INTERVENTION GROUP
  • Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
  • Aged 21 to 65

You likely can't join if

  • Visual impairments such as blindness which would impair them from watching the entertainment videos.
  • Patients with history of CAD,
  • History of seizures,
  • History of vertigo,
  • History of allergy to plastic,
  • ASAII or III,
See the full eligibility criteria
Who can join
  • INTERVENTION GROUP
  • Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
  • Aged 21 to 65
What rules you out
  • Visual impairments such as blindness which would impair them from watching the entertainment videos.
  • Patients with history of CAD,
  • History of seizures,
  • History of vertigo,
  • History of allergy to plastic,
  • ASAII or III,
  • Patient with active GI bleed, having either melena or hematochezia. CONTROL GROUP Inclusion Criteria:
  • Underwent screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
  • Aged 21 to 65 Exclusion Criteria:
  • Visual impairments such as blindness which would impair them from watching the entertainment videos
  • Patients with history of CAD
  • History of seizures
  • History of vertigo
  • History of allergy to plastic
  • ASAII or III
  • Patient with active GI bleed, having either melena or hematochezia

The study team makes the final eligibility decision.

Where it's taking place

  • Brooklyn, New York, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Brooklyn, New York, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.